MedPath

GD-MIRTAZAPINE OD

GD-MIRTAZAPINE OD

Discontinued
DIN Number

02352826

Drug Class

Human

Market Date

Apr 26, 2012

Company
HC

genmed a division of pfizer canada ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02352826
AIG Number0143928001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AX11 MIRTAZAPINE
Product Specifications
Dosage FormTablet (Orally Disintegrating)
Route of AdministrationOral
AHFS Classification28:16.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

MIRTAZAPINEActive
Strength: 15 MG
Monograph: MIRTAZAPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.